Organization · Venture Capital
JStar Capital Investments
JStar Capital Investments is a healthcare investment firm based in the United States, focusing on the med-tech sector. With over $100 million in capital, it targets late-stage healthcare companies poised for monetization or strategic exit.
Overview
What JStar Capital Investments does
What JStar Capital Investments is
JStar Capital Investments is a healthcare investment firm based in the United States, focusing on the med-tech sector. With over $100 million in capital, it targets late-stage healthcare companies poised for monetization or strategic exit.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 2, 2026
Official channels
Find JStar Capital Investments elsewhere
Open the official website or a supported primary organization account.
Capability profile
JStar Capital Investments as a funder
Investment thesis
JStar Capital Investments backs healthcare innovations where clinical impact, commercialization readiness, and strategic exit potential overlap, focusing on technologies that improve patient outcomes and lower costs.
Focus narrative
JStar Capital specializes in breakthrough medical technologies and services, particularly in cardiovascular and stroke protection, orthopedic technologies, biopharma solutions, and digital health innovations. The organization targets late-stage companies that demonstrate clinical validation and a clear path to scalable adoption.
Value beyond capital
JStar Capital provides strategic support to portfolio companies by leveraging its network of healthcare and financial experts. The firm emphasizes clinical depth, commercial intelligence, and capital efficiency, helping companies navigate regulatory, reimbursement, and adoption pathways.
Focus and fit
- Stages
- Series B · Growth Equity
- Sectors
- Healthcare · Biotech · Digital Health · Medical Devices
- Regions
- United States · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Sonavex: Develops EchoMark and EchoSure technology for assessing arteriovenous fistula maturation in dialysis clinics. Website Adhere Plus (PainScript): Connects physicians with chronic pain and substance use disorder patients through a medication adherence app. Website OsteoCentric: Offers UnifiMI® technology for multi-axial stability in orthopedic and dental applications. Website Emblok: Provides an embolic protection system for TAVR procedures. Website Egg Medical: Develops the EggNest™ Radiation Protection System to reduce radiation exposure during interventional procedures. Website Zetagen: Focuses on breakthrough oncology therapies for cancer treatment. Website Significo: A leader in health AI and digital therapeutics, offering solutions for personalized care. Website
Common questions
What to know about JStar Capital Investments
Upseed classifies JStar Capital Investments under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 2, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.